Patent Issued for Prosthetic heart valve (USPTO 12090048).

A patent has been issued for a prosthetic heart valve developed by Cardiovalve Ltd. The valve is designed to address regurgitation caused by ischemic heart disease, which leads to the displacement of papillary muscles and dilation of the valve annulus. The implantable device consists of a tubular portion, an upstream support portion, and flanges. It can be delivered percutaneously and secured at the native valve by sandwiching tissue between the upstream support portion and the flanges. The patent provides detailed descriptions of the apparatus and its components. [Extracted from the article]